Sign up to save your podcasts
Or
Share A Therapy for NASH, Another Alzheimer's Competitor, and Reflections on 2022
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Therapy for NASH, Another Alzheimer's Competitor, and Reflections on 2022
This week on the podcast Agustin discusses Madrigal Pharmaceuticals' recent phase III win in NASH, he highlights another monoclonal antibody in the Alzheimer's space, and provides a reflection on the markets in 2022.
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
View all episodes
By Biotech Bros LLC.This week on the podcast Agustin discusses Madrigal Pharmaceuticals' recent phase III win in NASH, he highlights another monoclonal antibody in the Alzheimer's space, and provides a reflection on the markets in 2022.
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com